Literature DB >> 21874549

Spontaneous spinal epidural haematoma during Factor Xa inhibitor treatment (Rivaroxaban).

M Jaeger1, B Jeanneret, S Schaeren.   

Abstract

We report on a 61-year-old female patient who developed a spontaneous spinal epidural haematoma (SSEH) after being treated by rivaroxaban, a new agent for the prevention of venous thromboembolic events in orthopaedic surgery. Although the pathogenesis of SSEH is unclear, anticoagulant therapy is a known risk factor. The patient sustained a sudden onset of severe back pain in the thoracic spine, followed by paraplegia below T8, 2 days after proximal tibial osteotomy and rivaroxaban therapy. Magnetic resonance imaging (MRI) of the whole spine demonstrated a ventral SSEH from C2 to T8. Whilst preparing for the emergency evacuation of the SSEH, the neurological symptoms recovered spontaneously 4 h after onset without surgery. After monitored bed rest for 48 h the MRI was repeated and the SSEH was no longer present. This rare condition of spinal cord compression and unusually rapid spontaneous recovery has not previously been reported following rivaroxaban therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874549      PMCID: PMC3369027          DOI: 10.1007/s00586-011-2003-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  13 in total

1.  Spontaneous spinal epidural hematoma.

Authors:  J Inamasu; S Hori; K Aoki; N Aikawa; H Maruiwa; Y Toyama
Journal:  Am J Emerg Med       Date:  2000-11       Impact factor: 2.469

Review 2.  Nontraumatic spinal epidural hematoma: report of four cases and review of the literature.

Authors:  M M Lonjon; P Paquis; S Chanalet; P Grellier
Journal:  Neurosurgery       Date:  1997-08       Impact factor: 4.654

3.  Surgical management of spontaneous spinal epidural hematoma.

Authors:  Jun-Jae Shin; Sung-Uk Kuh; Yong-Eun Cho
Journal:  Eur Spine J       Date:  2006-04-25       Impact factor: 3.134

4.  Spontaneous spinal epidural hematoma after seizure: a case report.

Authors:  Ahmet Güzel; Osman Simşek; Serap Karasalihoğlu; Yasemin Küçükuğurluoğlu; Betül Acunaş; Alptekin Tosun; Bilge Cakir
Journal:  Clin Pediatr (Phila)       Date:  2007-04       Impact factor: 1.168

5.  Spontaneous resolution of an acute spontaneous spinal epidural hematoma without neurological deficits.

Authors:  Y Serizawa; K Ohshiro; K Tanaka; S Tamaki; K Matsuura; T Uchihara
Journal:  Intern Med       Date:  1995-10       Impact factor: 1.271

6.  Spontaneous cervical epidural hematoma. A consideration of etiology.

Authors:  R M Beatty; K R Winston
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

7.  The syndrome of spontaneous spinal epidural hematoma. Report of three cases.

Authors:  J W Markham; H N Lynge; G E Stahlman
Journal:  J Neurosurg       Date:  1967-03       Impact factor: 5.115

8.  Spontaneous spinal epidural hematoma: findings at MR imaging and clinical correlation.

Authors:  S Holtås; M Heiling; M Lönntoft
Journal:  Radiology       Date:  1996-05       Impact factor: 11.105

Review 9.  [Rivaroxaban (Xarelto): efficacy and safety].

Authors:  N Rosencher; L Arnaout; T Chabbouh; L Bellamy
Journal:  Ann Fr Anesth Reanim       Date:  2008-12

Review 10.  Non-operative treatment of spontaneous spinal epidural hematomas: a review of the literature and a comparison with operative cases.

Authors:  R J M Groen
Journal:  Acta Neurochir (Wien)       Date:  2003-12-05       Impact factor: 2.216

View more
  19 in total

1.  Spinal subarachnoid hemorrhage in cortical superficial siderosis after apixaban and clopidogrel therapy.

Authors:  Josef G Heckmann
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

Review 2.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

3.  Nontraumatic spinal subdural hematoma complicating direct factor Xa inhibitor treatment (rivaroxaban): a challenging management.

Authors:  Cyril Dargazanli; Nicolas Lonjon; Guillaume Gras-Combe
Journal:  Eur Spine J       Date:  2015-07-31       Impact factor: 3.134

4.  Spontaneous spinal epidural haematoma mimicking acute coronary syndrome.

Authors:  Noor Mohammed; Muhammad Shahid; Munirul Haque; Masood Qureshi; Edward T D Hoey
Journal:  Quant Imaging Med Surg       Date:  2015-12

5.  Spontaneous spinal epidural hematoma in a patient with acquired Factor X deficiency secondary to systemic amyloid light-chain amyloidosis.

Authors:  Hidetaka Arishima; Ayumi Tada; Makoto Isozaki; Ryuhei Kitai; Toshiaki Kodera; Ken-ichiro Kikuta; Katsunori Tai; Hiromichi Iwasaki
Journal:  J Spinal Cord Med       Date:  2014-06-29       Impact factor: 1.985

6.  Non-Traumatic Spontaneous Spinal Subdural Hematoma in a Patient with Non-Valvular Atrial Fibrillation During Treatment with Rivaroxaban.

Authors:  Jessica M Castillo; Hayley F Afanador; Efren Manjarrez; Ximena A Morales
Journal:  Am J Case Rep       Date:  2015-06-19

7.  Rivaroxaban-associated Delayed Spontaneous Periprosthetic Hematoma.

Authors:  Kyra L Sierakowski; Nicola R Dean
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-07-08

8.  Spontaneous rectus sheath hematoma during rivaroxaban therapy.

Authors:  Ibrahim Kocayigit; Yusuf Can; Salih Sahinkus; Ercan Aydın; Mehmet Bulent Vatan; Harun Kılıc; Huseyin Gunduz
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

Review 9.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

10.  Rivaroxaban-Induced Nontraumatic Spinal Subdural Hematoma: An Uncommon Yet Life-Threatening Complication.

Authors:  Mazen Zaarour; Samer Hassan; Nishitha Thumallapally; Qun Dai
Journal:  Case Rep Hematol       Date:  2015-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.